Micrometastasis in colorectal carcinoma: A review

Journal of Surgical Oncology

Volumn 67, Issue 3, 1998, Pages 194-202

  Calaluce, Robert ^a,b   Miedema, Brent W ^a   Yesus, Yohannes W ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Colorectal carcinoma; Immunohistochemistry; Micrometastasis; Molecular diagnostics

Indexed keywords

ACCURACY; CANCER STAGING; COLORECTAL CARCINOMA; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MOLECULAR GENETICS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

BONE MARROW; BONE MARROW NEOPLASMS; COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0031916036     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199803)67:3<194::AID-JSO11>3.0.CO;2-2     Document Type: Review

References (51)

1. Saphir O, Amromin GD: Obscure axillary lymph-node metastasis in carcinoma of the breast. Cancer 1948;1:238-241.
2. Pickren JW: Significance of occult metastases: A study of breast cancer. Cancer 1961;14:1266-1271.
3. Huvos AG, Hutter RVP, Berg JW: Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surgery 1971;173:44-46.
4. Brennan JA, Mao L, Hruban RH, et al.: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med 1995;332:429-435.
5. Cawthorn SJ, Gibbs NM, Marks CG: Clearance technique for the detection of lymph nodes in colorectal cancer. Br J Surg 1986; 73:58-60.
6. Jass JR, Miller K, Northover JMA: Fat clearance method versus manual dissection of lymph nodes in specimens of rectal cancer. Int J Colorectal Dis 1986;1:155-156.
7. O'Brien MJ, Zamcheck N, Burke B, et al.: Immunocytochemical localization of carcinoembryonic antigen in benign and malignant colorectal tissues. Am J Clin Pathol 1981;75:283-290.
8. Davidson BR, Sams VR, Styles J, et al.: Detection of occult nodal metastases in patients with colorectal carcinoma. Cancer 1990;65: 967-970.
9. Cutait R, Alves VAF, Lopes LC, et al.: Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917-920.
10. Jeffers MD, O'Dowd GM, Mulcahy H, et al.: The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-187.
11. Adell G, Boeryd B, Franlund B, et al.: Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: An immunohistochemical study. Eur J Surg 1996;162:637-642.
12. Greenson JK, Isenhart CE, Rice R, et al.: Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: Correlation with long-term survival. Cancer 1994;73: 563-569.
13. Haboubi NY, Clark P, Kaftan SM, Schofield PF: The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 1992;85: 386-388.
14. Nicholson AG, Marks CG, Cook MG: Effect on lymph node status of triple levelling and immunohistochemistry with CAM 5.2 on node negative colorectal carcinomas. Gut 1994;35:1447-1448.
15. 125I-radiolabeled monoclonal antibody CC49. Cancer 1996;77:613-620.
16. Listrom MB, Little JV, McKinley M, Fenoglio-Preiser CM: Immunoreactivity of tumor-associated glycoprotein (TAG-72) in normal, hyperplastic, and neoplastic colon. Hum Pathol 1989;20: 994-1000.
17. Stramignoni D, Bowen R, Atkinson BF, Schlom J: Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas. Int J Cancer 1983;31:543-552.
18. Ohuchi N, Thor A, Nose M, et al.: Tumor-associated glycoprotein (TAG-72) detected in adenocarcinomas and benign lesions of the stomach. Int J Cancer 1986;38:643-650.
19. Mazur MT, Shultz JJ: Prostatic adenocarcinoma: Evaluation of immunoreactivity to monoclonal antibody B72.3. Am J Clin Pathol 1990;93:466-470.
20. Thor A, Viglione MJ, Muraro R, et al.: Monoclonal antibody B72.3 reactivity with human endometrium: A study of normal and malignant tissues. Int J Gynecol Pathol 1987;6:235-247.
21. Tavassoli FA, Jones MW, Majeste RM, et al.: Immunohistochemical staining with monoclonal Ab B72.3 in benign and malignant breast disease. Am J Surg Pathol 1990;14:128-133.
22. Loy TS, Haege DD: B72.3 immunoreactivity in benign abdominal lymph nodes associated with gastrointestinal disease. Dis Colon Rectum 1995;38:983-987.
23. Schlimok G, Funke I, Holzmann B, et al.: Micrometastatic cancer cells in bone marrow: In vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc Natl Acad Sci USA 1987;84:8672-8676.
24. Braun S, Pantel K: Immunodiagnosis and immunotherapy of isolated tumor cells disseminated to bone marrow of patients with colorectal cancer. Tumori 1995;81 Suppl:78-83.
25. Schlimok G, Funke I, Bock B, et al.: Epithelial tumor cells in bone marrow of patients with colorectal cancer: Immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 1990;8:831-837.
26. Lindemann F, Schlimok G, Dirschedl P, et al.: Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992;340:685-689.
27. Silly H, Samonigg H, Stöger H, et al.: Micrometastatic tumour cells in bone marrow in colorectal cancer. Lancet 1992;340:1288.
28. Pantel K, Braun S, Schlimok G, Riethmüller G: Micrometastatic tumour cells in bone marrow in colorectal cancer. Lancet 1993; 341:501.
29. Juhl H, Stritzel M, Wroblewski A, et al.: Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994;57: 330-335.
30. nd ed. Philadelphia: WB Saunders, 1994, p425-426.
31. Swanson PE: HIERanarchy: The state of the art in immunohistochemistry. Am J Clin Pathol 1997;107:139-140.
32. Saiki RK, Gelfand DH, Stoffel S, et al.: Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487-491.
33. Smith B, Selby P, Southgate J, et al.: Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-1229.
34. Mattano LA Jr, Moss TJ, Emerson SG: Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52:4701-4705.
35. Moreno JG, Croce CM, Fischer R, et al.: Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992;52:6110-6112.
36. Mori M, Mimori K, Inoue H, et al.: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-3420.
37. nd ed. Philadelphia: WB Saunders, Company, 1994:292-317.
38. Hayashi N, Arakawa H, Nagase H, et al.: Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res 1994;54:3853-3856.
39. Hayashi N, Ito I, Yanagisawa A, et al.: Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 1995;345: 1257-1259
40. Hardingham JE, Kotasek D, Farmer B, et al.: Immunobead-PCR: A technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 1993;53:3455-3458.
41. Hardingham JE, Kotasek D, Sage RE, et al.: Detection of circulating tumor cells in colorectal cancer by immunobead-PCR is a sensitive prognostic marker for relapse of disease. Mol Med 1995; 1:789-794.
42. Soeth E, Röder C, Juhl H, et al.: The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996;69:278-282.
43. Burchill SA, Bradbury MF, Pittman K, et al.: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278-281.
44. Neumaier M, Gerhard M, Wagener C: Diagnosis of micrometastases by the amplification of tissue-specific genes. Gene 1995; 159:43-47.
45. Strachan T, Read AP (eds): "Human Molecular Genetics." New York: John Wiley & Sons, 1996.
46. Sloane JP: Molecules and micrometastases. Lancet 1995;345: 1255-1256.
47. Goldrick MM, Kimball GR, Liu Q, et al.: NIRCA(R): a rapid robust method for screening for unknown point mutations. BioTechniques 1996;21:106-112.
48. Goldstein NS, Sanford W, Coffey M, Layfield LJ: Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209-216.
49. th ed. St. Louis: Mosby-Year Book, 1996.
50. Giuliano AE, Dale PS, Turner RR, et al.: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
51. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990;61:759-767.